LAURUS LABS
Back to Cashflow Statement
|
LAURUS LABS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹39 Cr | ₹250 Cr | ₹-27 Cr | ₹30 Cr | ₹255 Cr |
What is the latest Cash Flow from Financing Activities ratio of LAURUS LABS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2025 | ₹39 Cr |
Mar2024 | ₹250 Cr |
Mar2023 | ₹-27 Cr |
Mar2022 | ₹30 Cr |
Mar2021 | ₹255 Cr |
How is Cash Flow from Financing Activities of LAURUS LABS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹39 Cr | -84.28 | |
Mar2024 | ₹250 Cr | Positive | |
Mar2023 | ₹-27 Cr | Negative | |
Mar2022 | ₹30 Cr | -88.12 | |
Mar2021 | ₹255 Cr | - |
Compare Cash Flow from Financing Activities of peers of LAURUS LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LAURUS LABS | ₹42,685.1 Cr | 1.9% | 18.7% | 65.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,289.0 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,397.0 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
CIPLA | ₹119,955.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,132.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,657.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
LAURUS LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LAURUS LABS | 1.9% |
18.7% |
65.4% |
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses